These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 22926853

  • 1. A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
    Sühs KW, Hein K, Sättler MB, Görlitz A, Ciupka C, Scholz K, Käsmann-Kellner B, Papanagiotou P, Schäffler N, Restemeyer C, Bittersohl D, Hassenstein A, Seitz B, Reith W, Fassbender K, Hilgers R, Heesen C, Bähr M, Diem R.
    Ann Neurol; 2012 Aug; 72(2):199-210. PubMed ID: 22926853
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis.
    Roed HG, Langkilde A, Sellebjerg F, Lauritzen M, Bang P, Mørup A, Frederiksen JL.
    Neurology; 2005 Mar 08; 64(5):804-10. PubMed ID: 15753413
    [Abstract] [Full Text] [Related]

  • 4. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.
    Pueyo V, Martin J, Fernandez J, Almarcegui C, Ara J, Egea C, Pablo L, Honrubia F.
    Mult Scler; 2008 Jun 08; 14(5):609-14. PubMed ID: 18424482
    [Abstract] [Full Text] [Related]

  • 5. Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.
    Diem R, Molnar F, Beisse F, Gross N, Drüschler K, Heinrich SP, Joachimsen L, Rauer S, Pielen A, Sühs KW, Linker RA, Huchzermeyer C, Albrecht P, Hassenstein A, Aktas O, Guthoff T, Tonagel F, Kernstock C, Hartmann K, Kümpfel T, Hein K, van Oterendorp C, Grotejohann B, Ihorst G, Maurer J, Müller M, Volkmann M, Wildemann B, Platten M, Wick W, Heesen C, Schiefer U, Wolf S, Lagrèze WA.
    BMJ Open; 2016 Mar 01; 6(3):e010956. PubMed ID: 26932144
    [Abstract] [Full Text] [Related]

  • 6. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography.
    Costello F, Hodge W, Pan YI, Eggenberger E, Coupland S, Kardon RH.
    Mult Scler; 2008 Aug 01; 14(7):893-905. PubMed ID: 18573837
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
    Shayegannejad V, Shahzamani S, Dehghani A, Dast Borhan Z, Rahimi M, Mirmohammadsadeghi A.
    Graefes Arch Clin Exp Ophthalmol; 2015 May 01; 253(5):797-801. PubMed ID: 25605544
    [Abstract] [Full Text] [Related]

  • 8. Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis.
    Pro MJ, Pons ME, Liebmann JM, Ritch R, Zafar S, Lefton D, Kupersmith MJ.
    J Neurol Sci; 2006 Dec 01; 250(1-2):114-9. PubMed ID: 17027854
    [Abstract] [Full Text] [Related]

  • 9. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L, Castelnovo G, Carlander B, Villain M, Mura F, Dupeyron G, Labauge P.
    Rev Neurol (Paris); 2008 Nov 01; 164(11):927-34. PubMed ID: 18808761
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Axonal loss and myelin in early ON loss in postacute optic neuritis.
    Klistorner A, Arvind H, Nguyen T, Garrick R, Paine M, Graham S, O'Day J, Grigg J, Billson F, Yiannikas C.
    Ann Neurol; 2008 Sep 01; 64(3):325-31. PubMed ID: 18825673
    [Abstract] [Full Text] [Related]

  • 12. Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin.
    Sühs KW, Papanagiotou P, Hein K, Pul R, Scholz K, Heesen C, Diem R.
    Int J Mol Sci; 2016 Sep 30; 17(10):. PubMed ID: 27706045
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study.
    Lagrèze WA, Küchlin S, Ihorst G, Grotejohann B, Beisse F, Volkmann M, Heinrich SP, Albrecht P, Ungewiss J, Wörner M, Hug MJ, Wolf S, Diem R, TONE study group.
    Lancet Neurol; 2021 Dec 30; 20(12):991-1000. PubMed ID: 34800417
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized control trial of evaluation of Clemastine effects on visual evoked potential, nerve fiber layer and ganglion cell layer complex in patients with optic neuritis.
    Moghaddasi M, Nabovvati M, Koushki A, Soltansanjari M, Sardarinia M, Mohebi N, Rabani S.
    Clin Neurol Neurosurg; 2020 Jun 30; 193():105741. PubMed ID: 32145678
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictive value of 1 month retinal nerve fiber layer thinning for deficits at 6 months after acute optic neuritis.
    Kupersmith MJ, Anderson S, Kardon R.
    Mult Scler; 2013 Nov 30; 19(13):1743-8. PubMed ID: 23698127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.